Effectiveness of Digital Marketing Strategies to Improve Adherence to Chronic Medications
NCT ID: NCT06599333
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
192 participants
OBSERVATIONAL
2024-07-15
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Exploring cost-effective and scalable interventions like digital marketing becomes vital in this context. Lebanon has a high internet and mobile phone penetration rate, which presents an opportunity for leveraging digital tools to promote health. By utilizing culturally tailored messaging and communication strategies, the e-MedAL Study has the potential to improve medication adherence rates significantly. This, in turn, would alleviate the burden on healthcare resources, enhance patient outcomes, and reduce the economic impact of poorly managed chronic diseases in the country. Furthermore, the success of this initiative could serve as a model for other countries in the region facing similar healthcare challenges. Lebanon's diverse and tech-savvy population makes it an ideal test case for assessing the role of digital marketing in healthcare, particularly in resource-constrained settings.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence
NCT05645653
Healthcare Professionals' Attitude Towards Clinical Research in the United Arab Emirates
NCT06531616
Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman
NCT06951451
Leveraging mHealth Messaging to Promote Adherence in Teens With CKD
NCT03651596
Increasing Medication Adherence Through Physician Incentives and Messaging
NCT01603329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Study Overview and Purpose Chronic diseases like diabetes, hypertension, and cardiovascular disorders are growing global health concerns. One of the biggest challenges is ensuring long-term adherence to prescribed treatments, which, if not followed, leads to poor health outcomes and higher healthcare costs .
The e-MedAL study investigates how digital marketing strategies-such as mobile applications, social media campaigns, and online education-can improve medication adherence among patients in Lebanon . It evaluates the local healthcare infrastructure and cultural factors affecting adherence.
2. State of Digital Marketing in Healthcare Digital marketing has revolutionized how healthcare providers engage with patients. By offering more personalized and interactive communication channels, it provides opportunities to boost medication adherence. Digital tools like reminders, educational campaigns, and behavioral nudges have been shown to improve adherence by as much as 17% across various chronic diseases .
Lebanon's high internet penetration presents an opportunity to implement these strategies. However, the country also faces unique challenges, such as a fragmented healthcare system, economic difficulties, and a reliance on out-of-pocket payments, making adherence a significant issue .
3. Research Format and Methodology (PECO) Population: Patients residing in Lebanon who have been taking chronic medications for at least six months.
Exposure: The use of digital marketing strategies to improve medication adherence.
Comparison: A questionnaire-based assessment to evaluate patients' perceptions and readiness to adopt digital marketing strategies.
Outcomes: Correlation between the effectiveness of digital strategies and patient adherence, along with demographic characteristics.
4. Questionnaire Sections General Characteristics: Participants provide demographic information such as age, education, smoking habits, and economic status .
Medical and Medication History: Participants detail their chronic conditions, medication routines, and healthcare provider preferences .
Adherence Assessment: Using a Likert scale, participants assess how closely they follow their prescribed medication regimen .
Effectiveness of Digital Marketing: This section assesses how digital reminders, educational content, social media, and telemedicine services influence medication adherence .
Perceived Barriers: Participants indicate potential challenges in using digital health tools, such as internet access, privacy concerns, and trust in digital channels .
5. Study Timeline and Outcome The study began on July 15th, 2024, and is ongoing (IRB Faculty of Pharmacy, Lebanese University).
The expected outcomes include a thesis, a scientific publication, and possibly a presentation at an international conference .
The study aims to provide insights that could serve as a model for other countries facing similar healthcare challenges, particularly in resource-constrained settings like Lebanon.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients coming to community pharmacies and taking at least the same medication for 6 months
Adherence to Care
Questionnaire to assess the perception and readiness of patients in Lebanon towards the effectiveness of digital marketing strategies to improve their adherence to medications they take chronically
The following sections will be considered:
* General Characteristics of the Participants
* Medical and medication history
* Assessment of adherence to chronic medications (Likert scale)
* Digital Marketing Strategies to improve adherence to chronic medications (Likert scale)
* Perceived barriers to adopting digital marketing strategies in Lebanon (Likert scale)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adherence to Care
Questionnaire to assess the perception and readiness of patients in Lebanon towards the effectiveness of digital marketing strategies to improve their adherence to medications they take chronically
The following sections will be considered:
* General Characteristics of the Participants
* Medical and medication history
* Assessment of adherence to chronic medications (Likert scale)
* Digital Marketing Strategies to improve adherence to chronic medications (Likert scale)
* Perceived barriers to adopting digital marketing strategies in Lebanon (Likert scale)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lebanese patients
* Those who agree to participate in the study
Exclusion Criteria
* Those who are not themselves responsible for purchasing the medications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lebanese University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Georges Hatem
Associate Clinical and Epidemiological Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georges Hatem
Role: PRINCIPAL_INVESTIGATOR
Lebanese University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lebanese University
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18/24/D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.